NCT04369807
- Conditions
- Body Weight, COVID-19, Coronaviridae Infections, +26 more
- Locations
-
- Mayo Clinic Healthcare London, United Kingdom
- Gemini Oxford, United Kingdom
Clinical trial condition
Explore clinical trials studying Hyperinsulinism. Study availability and eligibility vary by location and protocol.
NCT04369807
NCT05088954
NCT07260201
NCT07260487
NCT05649176
NCT04771754
NCT03422848
NCT00628524
NCT06935058
NCT01201603